Cannabis may be protective against liver disease
Search Results for: liver disease
Subjects who consume cannabis are significantly less likely to suffer from non-alcoholic fatty liver disease (NAFLD) as compared to those who do not…
Montreal, Canada: Marijuana smoking is not associated with the promotion of liver disease in subjects…
Marijuana smoking is not associated with the promotion of liver disease in subjects coinfected with both hepatitis C and the human immunodeficiency virus (HIV), according to data published online in the journal Clinical Infectious Diseases. Researchers concluded: “[I]n this first prospective evaluation of liver disease progression among HIV-HCV infected persons, we could not demonstrate any important effect of marijuana on liver disease outcomes. A causal association is unlikely: hazard ratios were weak and … there was no dose-response relationship. It is likely that previous studies have been biased by reverse causality as patients use more marijuana to relieve symptoms as liver disease progresses.”
Researchers identified no changes in patients’ enzyme levels in a manner that would be indicative of liver damage.
“This is the first and largest population-based cross-sectional study of hospitalized patients to explore the association between cannabis use and HCC,” authors concluded.
Researchers reported that the repeated use of oral CBD products was not associated with liver abnormalities, including the elevated production of certain liver enzymes.
“What we observed to date is no clinical evidence of liver disease in any participants.”